US 11,884,650 B2
Substituted heterocyclic compounds
Steven H. Spergel, Warrington, PA (US); Ryan M. Moslin, Princeton, NJ (US); and Michael Edward Mertzman, New Hope, PA (US)
Assigned to BRISTOL-MYERS SQUIBB COMPANY, Princeton, NJ (US)
Filed by BRISTOL-MYERS SQUIBB COMPANY, Princeton, NJ (US)
Filed on May 13, 2022, as Appl. No. 17/743,615.
Claims priority of provisional application 63/318,508, filed on Mar. 10, 2022.
Claims priority of provisional application 63/188,498, filed on May 14, 2021.
Prior Publication US 2022/0388987 A1, Dec. 8, 2022
Int. Cl. C07D 401/14 (2006.01); C07D 401/12 (2006.01)
CPC C07D 401/14 (2013.01) [C07D 401/12 (2013.01)] 6 Claims
 
1. A compound of formula I

OG Complex Work Unit Chemistry
or a stereoisomer or pharmaceutically acceptable salt thereof,
wherein
X is —N— or —CH—;
R1 is —C(O)R1a;
R1a is C3-6 cycloalkyl;
R2 is C1-6 alkoxy;
R3 is C1-6 alkyl or C3-6 cycloalkyl.